This work describes a rare case of serous carcinoma coexistence with atypical polypoid adenomyoma (APA). A 55-year-old postmenopausal woman presented with intermittent vaginal bleeding for 1 year. Her Pap test exhibited atypical glandular cell and endometrial biopsy showed serous carcinoma. She underwent a staging surgery, and the histopathology revealed serous carcinoma with p53 mutation and coexistence with APA staged as FIGO Stage Ia, Grade 1. The patient recovered well postoperatively. APA lesion is generally benign, but it may progress in rare cases to adenocarcinoma, usually endometrioid type. This is the first case report regarding serous carcinoma coexistence with APA. Therefore, the patient with APA should always be closely followe...
Objective: Atypical polypoid adenomyoma (APAM) is an epithelial-mesenchymal mixed tumor which often ...
Atypical polypoid adenomyoma (APA) may progress to endometrioid carcinoma and may mimic myoinvasive ...
BACKGROUND: Endometrial cancer is the third-ranked genital malignancy in women and includes 3% of ca...
Uterine serous carcinoma (USC) is a rare variant of endometrial cancer that is not related to increa...
Atypical polypoid adenomyoma is a rare and benign polypoid lesion of uterus with proliferation of ir...
Adenocarcinoma arising from adenomyosis uteri is rare. Herein, we reported a patient with papillary ...
Objective: Endometrial cancer (EC) is the most commonly diagnosed malignancy and has the second-high...
Introduction: Carcinosarcoma is a rare gynecological malignancy and it usually follows an aggressive...
SummaryObjectiveMalignant transformations of adenomyosis in premenopausal women with normal endometr...
Serous carcinoma is the prototype of type II endometrial carcinoma. A 71-year-old woman who had hist...
AbstractThis case report presents a 66-year-old postmenopausal woman with a case of endometrial aden...
Objective: To provide a reference for the diagnosis and treatment of atypical polypoid adenomyoma (A...
Multiple primary malignant tumors (MPMTs) refer to two or more primary malignant neoplasms that simu...
Mullerian adenosarcoma is a biphasic neoplasm composed of benign or atypical Müllerian epithelium an...
Endometrial serous carcinomas are very clinically aggressive, which constitutes 40% of all deaths an...
Objective: Atypical polypoid adenomyoma (APAM) is an epithelial-mesenchymal mixed tumor which often ...
Atypical polypoid adenomyoma (APA) may progress to endometrioid carcinoma and may mimic myoinvasive ...
BACKGROUND: Endometrial cancer is the third-ranked genital malignancy in women and includes 3% of ca...
Uterine serous carcinoma (USC) is a rare variant of endometrial cancer that is not related to increa...
Atypical polypoid adenomyoma is a rare and benign polypoid lesion of uterus with proliferation of ir...
Adenocarcinoma arising from adenomyosis uteri is rare. Herein, we reported a patient with papillary ...
Objective: Endometrial cancer (EC) is the most commonly diagnosed malignancy and has the second-high...
Introduction: Carcinosarcoma is a rare gynecological malignancy and it usually follows an aggressive...
SummaryObjectiveMalignant transformations of adenomyosis in premenopausal women with normal endometr...
Serous carcinoma is the prototype of type II endometrial carcinoma. A 71-year-old woman who had hist...
AbstractThis case report presents a 66-year-old postmenopausal woman with a case of endometrial aden...
Objective: To provide a reference for the diagnosis and treatment of atypical polypoid adenomyoma (A...
Multiple primary malignant tumors (MPMTs) refer to two or more primary malignant neoplasms that simu...
Mullerian adenosarcoma is a biphasic neoplasm composed of benign or atypical Müllerian epithelium an...
Endometrial serous carcinomas are very clinically aggressive, which constitutes 40% of all deaths an...
Objective: Atypical polypoid adenomyoma (APAM) is an epithelial-mesenchymal mixed tumor which often ...
Atypical polypoid adenomyoma (APA) may progress to endometrioid carcinoma and may mimic myoinvasive ...
BACKGROUND: Endometrial cancer is the third-ranked genital malignancy in women and includes 3% of ca...